IRIS
VAGO, LUCA ALDO EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.181
NA - Nord America 838
AS - Asia 674
SA - Sud America 15
OC - Oceania 10
AF - Africa 3
Totale 2.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 828
SE - Svezia 618
SG - Singapore 291
IT - Italia 245
CN - Cina 235
RU - Federazione Russa 195
HK - Hong Kong 70
FI - Finlandia 41
JP - Giappone 38
DE - Germania 22
IE - Irlanda 16
IN - India 12
BR - Brasile 11
IR - Iran 11
AU - Australia 10
CA - Canada 10
GB - Regno Unito 10
SA - Arabia Saudita 9
FR - Francia 7
NL - Olanda 7
AT - Austria 6
HU - Ungheria 5
CL - Cile 4
CH - Svizzera 3
IL - Israele 3
PK - Pakistan 3
DZ - Algeria 2
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
IQ - Iraq 1
LT - Lituania 1
MK - Macedonia 1
RS - Serbia 1
TH - Thailandia 1
UA - Ucraina 1
Totale 2.721
Salva come PNG Salva come JPEG
Città #
Lawrence 225
Princeton 225
Singapore 202
Shanghai 110
Milan 98
Moscow 70
Ashburn 64
New York 48
Helsinki 36
Boardman 28
Dublin 16
Beijing 11
Chaoyang 10
Guangzhou 9
Shenzhen 9
Tokyo 9
Washington 8
Gorgonzola 7
Los Angeles 7
Rome 7
Seattle 7
Bologna 6
São Paulo 6
Borås 5
Budapest 5
Casale Monferrato 5
Falls Church 5
Genoa 5
Hanover 5
Jeddah 5
Jiaxing 5
Lappeenranta 5
New Haven 5
Overland Park 5
Perth 5
Aci Sant'Antonio 4
Andover 4
Baltimore 4
Elsternwick 4
Montreal 4
Naples 4
Pune 4
San Jose 4
Santiago 4
Wuxi 4
Ferrara 3
Gronau 3
Hangzhou 3
Ibaraki 3
Iowa City 3
Kfar Saba 3
Oberndorf bei Salzburg 3
Phoenix 3
Pisa 3
Santo André 3
Segrate 3
Turin 3
Vienna 3
Alagappapuram 2
Bergamo 2
Bordeaux 2
Boston 2
Bussero 2
Castelli Calepio 2
Castelseprio 2
Central 2
Cinisello Balsamo 2
Crotone 2
Dallas 2
Des Moines 2
Edgware 2
Ekimaedori 2
Figline Valdarno 2
Florence 2
Foshan 2
Frederick 2
Hong Kong 2
Kolkata 2
Livorno 2
L’Aquila 2
Maple 2
Mestre 2
Modena 2
Muzaffargarh 2
Nanjing 2
Padova 2
Palermo 2
Paris 2
Redwood City 2
Sheffield 2
Siena 2
St Louis 2
Surat 2
Toronto 2
Vanzago 2
Westmont 2
Xian 2
Zurich 2
Aioicho 1
Albuquerque 1
Totale 1.439
Salva come PNG Salva come JPEG
Nome #
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 76
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 71
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 43
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 42
Loss of mismatched HLA in leukemia after stem-cell transplantation 39
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 36
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 34
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 33
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 33
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 32
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 30
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 30
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 28
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 28
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 27
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 26
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 26
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 25
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 24
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 23
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 23
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 23
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 23
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 22
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 21
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 21
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 21
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 21
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 21
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 21
Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients 20
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 19
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 19
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 19
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 19
Clinical and molecular features associated with acute myeloid leukemia engraftment in immunodeficient mouse models 19
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti 19
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 18
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 18
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody 18
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 17
Improving the safety of cell therapy with the TK-suicide gene. 17
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 17
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 17
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 17
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 17
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 17
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 16
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 16
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 16
TREOSULFAN-BASED CONDITIONING AND UNMANIPULATED PERIPHERAL BLOOD HAPLOIDENTICAL TRANSPLANTATION (HAPLOSCT) FOR PRIMARY REFRACTORY AND RELAPSED AML: RESULTS IN 63 PATIENTS 16
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 16
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation 16
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party 15
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 15
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 15
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 15
Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation 15
Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease 15
Frequency and targeted detection of HILA-DPB1 alleles encoding non-permissive transplantation antigens 15
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 14
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 14
Genomic loss of mismatched HLA in leukemia is a major mechanism of in vivo escape from T cell immunosurveillance following haploidentical hematopoietic stem cell transplantation 14
The effect of donor-recipient KIR ligand incompatibility after haploidentical hematopoietic stem cell transplantation is overruled by biological characteristics of early reconstituting NK cells with impaired graft versus leukemia activity 14
Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia 14
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 14
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 14
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T EMRA lymphocytes 14
Significantly higher frequencies of alloreactive CD4(+) T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities 14
Mutation at Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 Is a More Refined but Less Adaptable NK Cell Receptor Than KIR2DL3 14
Early post-allogeneic transplantation WT1 transcript positivity predicts AML relapse 14
ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AND NORMAL KARYOTYPE HAVE A FAVOURABLE OUTCOME AFTER INTENSIVE THERAPEUTIC PROGRAMS 14
Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation 13
Haploidentical HSCT: a 15-year experience at San Raffaele. 13
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells 13
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 13
Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors 13
VORICONAZOLE PROPHYLAXIS OF INVASIVE FUNGAL INFECTION IN HAPLOIDENTICAL ALLOGENIC STEM CELL TRANSPLANTATION 13
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes 13
RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE 13
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 13
T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus 13
LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 13
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 13
Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity 13
Experts' considerations on HLA-haploidentical stem cell transplantation 12
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells 12
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 12
TK007 phase II study final analysis. Genetically modified donor lymphocytes abate transplant related mortality and increase leukaemia-free survival providing early immune reconstitution after haploidentical haematopoietic stem cell transplantation 12
Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009 12
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 12
Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation 12
Quantitative PCR for ins/del polymorphisms is a reliable and sensitive tool for host chimerism analysis after allogeneic hematopoietic stem cell transplantation 12
Epidemiology and biology of relapse after stem cell transplantation 12
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 12
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING 12
T CELL ORIGIN OF CYTOKINE INDUCED KILLER CELLS 12
Allogeneic haematopoietic stem cell transplantation in patients older than 65 years with high risk acute myeloid leukemia: results in 46 consecutive patients 12
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation 12
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 11
Totale 1.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 6 2 1 126 2 5 0 0 0
2021/2022144 0 0 0 34 12 8 6 21 22 18 10 13
2022/20231.263 493 293 82 10 43 136 38 79 49 14 17 9
2023/2024670 32 29 61 66 44 87 106 56 12 23 30 124
2024/2025697 429 66 62 86 54 0 0 0 0 0 0 0
Totale 2.978